Skip to content

Clinical Observation on the Efficacy of Electroacupuncture in Treating Neurogenic Bowel Dysfunction (Constipation Type) After Ischemic Stroke

Clinical Study of Electroacupuncture Treatment for Neurogenic Bowel Dysfunction (Constipation Type) in Patients with Ischemic Stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000184
Enrollment
Unknown
Registered
2024-08-07
Start date
2024-02-27
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurogenic bowel dysfunction(constipation type)

Interventions

Control Group:Oral lactulose solution was administered at a dose of 10 ml per intake, three times daily. Dosage and duration were adjusted based on the individual patients condition. The total treatme
Treatment group:Building upon the control group, acupuncture was performed at the Zusanli point. After local disinfection, a sterile, single-use acupuncture needle was quickly inserted into the acupoi

Sponsors

The Second People's Hospital of China Three Gorges University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: Imaging findings meet the diagnostic criteria for ischemic stroke; the patient experiences a significant reduction in bowel movements, decreased defecation frequency (once every 2-3 days or less), dry stools, and at least two of the following symptoms: difficulty in defecation. These symptoms occur after neurological impairment due to stroke. The patient must be 18 years or older, have clear consciousness, stable vital signs, and be able to cooperate with treatment. Enrollment requires a thorough understanding of the study and signing an informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria include patients with malignant tumors of the nervous or digestive systems; those with a history of rectal, colonic organic lesions, or bowel surgery; individuals with a history of habitual constipation or diarrhea, indicating bowel dysfunction; those with severe cardiac, hepatic, or renal dysfunction and/or hematologic diseases; individuals with fecal incontinence; and those with psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
Wexner Constipation Score;

Secondary

MeasureTime frame
Neurogenic Bowel Dysfunction Score;patient-assessment of constipation quality of life;Bowel movement frequency;Bowel movement time;

Countries

China

Contacts

Public ContactYu Li

The Second People's Hospital of China Three Gorges University

hsly63620@163.com13972028178

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026